Ifm Investors Pty LTD Regeneron Pharmaceuticals, Inc. Transaction History

Ifm Investors Pty LTD

$10.3 Billion
Q3 2024

A detailed history of Ifm Investors Pty LTD transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Ifm Investors Pty LTD holds 23,285 shares of REGN stock, worth $17.2 Million. This represents 0.24% of its overall portfolio holdings.

Number of Shares

23,285

Previous 23,258 0.12%

Holding current value

$17.2 Million

Previous $24.4 Million 0.14%

% of portfolio

0.24%

Previous 0.25%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$1024.09 - $1201.76 $27,650 - $32,447	27 Added 0.12%	23,285 $24.5 Million
Q2 2024 Aug 14, 2024	BUY	$883.2 - $1071.19 $609,408 - $739,121	690 Added 3.06%	23,258 $24.4 Million
Q1 2024 Apr 22, 2024	SELL	$902.69 - $993.35 $120,960 - $133,108	-134 Reduced 0.59%	22,568 $21.7 Million
Q4 2023 Jan 12, 2024	SELL	$775.18 - $881.7 $44,960 - $51,138	-58 Reduced 0.25%	22,702 $19.9 Million
Q3 2023 Oct 26, 2023	BUY	$692.45 - $844.37 $1.29 Million - $1.57 Million	1,859 Added 8.89%	22,760 $18.7 Million
Q2 2023 Jul 27, 2023	BUY	$700.03 - $830.35 $731,531 - $867,715	1,045 Added 5.26%	20,901 $15 Million
Q1 2023 May 11, 2023	BUY	$680.49 - $826.97 $317,108 - $385,368	466 Added 2.4%	19,856 $16.3 Million
Q4 2022 Feb 14, 2023	BUY	$705.89 - $766.39 $353,650 - $383,961	501 Added 2.65%	19,390 $14 Million
Q3 2022 Oct 12, 2022	BUY	$573.97 - $724.32 $215,812 - $272,344	376 Added 2.03%	18,889 $13 Million
Q2 2022 Jul 15, 2022	BUY	$548.35 - $738.84 $605,378 - $815,679	1,104 Added 6.34%	18,513 $10.9 Million
Q1 2022 Apr 13, 2022	BUY	$595.12 - $698.43 $2.18 Million - $2.56 Million	3,659 Added 26.61%	17,409 $12.2 Million
Q4 2021 Jan 18, 2022	SELL	$543.48 - $670.97 $35,869 - $44,284	-66 Reduced 0.48%	13,750 $8.68 Million
Q3 2021 Oct 13, 2021	SELL	$574.03 - $680.96 $20,091 - $23,833	-35 Reduced 0.25%	13,816 $8.36 Million
Q2 2021 Jul 16, 2021	BUY	$472.8 - $558.54 $1.09 Million - $1.29 Million	2,308 Added 19.99%	13,851 $7.74 Million
Q1 2021 May 05, 2021	BUY	$446.73 - $548.2 $680,369 - $834,908	1,523 Added 15.2%	11,543 $5.46 Million
Q4 2020 Jan 13, 2021	BUY	$478.3 - $607.98 $831,763 - $1.06 Million	1,739 Added 21.0%	10,020 $4.84 Million
Q3 2020 Oct 16, 2020	BUY	$544.75 - $658.21 $616,657 - $745,093	1,132 Added 15.83%	8,281 $4.64 Million
Q2 2020 Jul 13, 2020	SELL	$493.32 - $643.92 $545,611 - $712,175	-1,106 Reduced 13.4%	7,149 $4.46 Million
Q1 2020 Apr 09, 2020	BUY	$336.18 - $494.43 $83,708 - $123,113	249 Added 3.11%	8,255 $3.91 Million
Q4 2019 Jan 13, 2020	SELL	$274.13 - $376.51 $94,026 - $129,142	-343 Reduced 4.11%	8,006 $3.01 Million
Q3 2019 Nov 01, 2019	BUY	$273.46 - $318.39 $660,405 - $768,911	2,415 Added 40.7%	8,349 $2.32 Million
Q2 2019 Jul 16, 2019	BUY	$299.6 - $414.82 $176,164 - $243,914	588 Added 11.0%	5,934 $1.86 Million
Q1 2019 Apr 18, 2019	BUY	$372.08 - $439.57 $284,641 - $336,271	765 Added 16.7%	5,346 $2.2 Million
Q4 2018 Jan 23, 2019	BUY	$335.82 - $403.04 $143,059 - $171,695	426 Added 10.25%	4,581 $1.71 Million
Q3 2018 Oct 22, 2018	BUY	$351.14 - $408.51 $206,470 - $240,203	588 Added 16.48%	4,155 $1.68 Million
Q2 2018 Jul 09, 2018	BUY	$284.6 - $344.99 $317,329 - $384,663	1,115 Added 45.47%	3,567 $1.23 Million
Q1 2018 May 11, 2018	BUY	$315.82 - $393.78 $82,744 - $103,170	262 Added 11.96%	2,452 $844,000
Q3 2017 Nov 16, 2017	BUY	$431.38 - $504.0 $19,412 - $22,680	45 Added 2.1%	2,190 $979,000
Q2 2017 Nov 21, 2017	BUY	N/A	2,145 New	2,145 $1.05 Million
Q2 2017 Aug 10, 2017	SELL	N/A	-1,628 Closed	0 $0
Q1 2017 Nov 21, 2017	BUY	N/A	1,628	1,628 $631,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifm Investors Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Ifm Investors Pty LTD with notifications on news.

Account

Ifm Investors Pty LTD Regeneron Pharmaceuticals, Inc. Transaction History